certolizumab pegol

E2042587 UNEXPLORED

Certolizumab pegol is a PEGylated anti-TNFα monoclonal antibody fragment used to treat inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn’s disease.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
certolizumab pegol canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.